CRISPR Therapeutics AG Contracts & Agreements

70 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Share Issuance Agreement between CRISPR Therapeutics AG and Holder
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2025
Organizational Rules of CRISPR Therapeutics AG
Operating Agreements
CRISPR Therapeutics AG
Biotechnology
2025
Indemnification Agreement between CRISPR Therapeutics AG and Indemnitee
Indemnification Agreements
CRISPR Therapeutics AG
Biotechnology
2024
Employment Agreement between CRISPR Therapeutics, Inc. and Naimish Patel (Chief Medical Officer)
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2024
Investment Agreement between CRISPR Therapeutics AG and Investors (February 13, 2024)
Investment Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2024
Amendment No. 1 to Amended and Restated Joint Development and Commercialization Agreement between Vertex Pharmaceuticals and CRISPR Therapeutics
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2023
Employment Agreement between CRISPR Therapeutics, Inc. and Phuong Khanh Morrow
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2022
Employment Agreement between CRISPR Therapeutics, Inc. and Brendan Smith (CFO)
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2021
Amendment No. 1 to Strategic Collaboration and License Agreement between Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Assignment of Sublease and Sub-Sublease Agreement between Casebia Therapeutics LLC and CRISPR Therapeutics, Inc. (December 13, 2019)
Assignment Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Amendment No. 1 to Research Collaboration Agreement between ViaCyte, Inc. and CRISPR Therapeutics AG
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Amendment No. 2 to Research Collaboration Agreement between ViaCyte, Inc. and CRISPR Therapeutics AG
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Joint Venture Termination Agreement between Bayer and CRISPR Therapeutics (December 13, 2019)
Joint Venture Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2020
Retirement Agreement among Casebia Therapeutics LLP, Bayer HealthCare LLC, and CRISPR Therapeutics (December 2019)
Separation Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2020
Mandate Agreement between CRISPR Therapeutics AG and Oriolus Consulting LLC (2019)
Consulting Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Termination Agreement between CRISPR Therapeutics AG and Rodger Novak (December 27, 2019)
Separation Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Amendment No. 2 to Strategic Collaboration, Option and License Agreement between Vertex Pharmaceuticals and CRISPR Therapeutics
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Strategic Collaboration and License Agreement between Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2019
Employment Agreement between CRISPR Therapeutics, Inc. and Michael Tomsicek (November 13, 2017)
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2018
Employment Agreement between CRISPR Therapeutics, Inc. and James R. Kasinger (General Counsel and Secretary)
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2018
Employment Agreement between CRISPR Therapeutics, Inc. and Tony W. Ho (August 1, 2017)
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2018
CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Incentive Stock Option Agreement under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Non-Qualified Stock Option Agreement for Employees under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Warrant Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Non-Qualified Stock Option Agreement for Non-Employee Directors under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Warrant Agreements
CRISPR Therapeutics AG
Biotechnology
2018
CRISPR Therapeutics AG Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Advisory Agreement between CRISPR Therapeutics AG and N. Anthony Coles, MD
Advisory Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017
Employment Agreement between CRISPR Therapeutics AG and Rodger Novak (President) Effective December 1, 2017
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Joint Development and Commercialization Agreement between Vertex Pharmaceuticals and CRISPR Therapeutics
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
DE
2017
Amendment No. 1 to Strategic Collaboration, Option and License Agreement between Vertex Pharmaceuticals and CRISPR Therapeutics
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017
Incentive Stock Option Agreement under the CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Non-Qualified Stock Option Agreement for Employees under the CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan
Warrant Agreements
CRISPR Therapeutics AG
Biotechnology
2017
CRISPR Therapeutics AG Restricted Stock Unit Award Agreement for Employees under 2016 Stock Option and Incentive Plan
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Second Amended and Restated Employment Agreement between CRISPR Therapeutics, Inc. and Samarth Kulkarni
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017
CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Amended and Restated Employment Agreement between CRISPR Therapeutics, Inc. and Samarth Kulkarni
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017
Invention Management and Consent to Assignment Agreement for Programmable DNA Restriction Enzyme Patents (UC, Charpentier, Vienna, CRISPR, ERS, TRACR, Caribou, Intellia)
License Agreements
CRISPR Therapeutics AG
Biotechnology
CA
2016
CRISPR Therapeutics AG 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2016
CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2016
Consent to Sublease Agreement among MIT 650 Main Street LLC, Pfizer Inc., and CRISPR Therapeutics, Inc.
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2016
Description of CRISPR Therapeutics AG Common Shares Registered Under Section 12 of the Exchange Act
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2025
Description of CRISPR Therapeutics AG Common Shares Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2024
Lease Commencement Date Agreement between 105 W FIRST STREET OWNER, L.L.C. and CRISPR THERAPEUTICS, INC.
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2022
Description of CRISPR Therapeutics AG Common Shares Registered Under Section 12 of the Exchange Act
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2022
Amendment to Sublease Agreements between Pfizer Inc. and CRISPR Therapeutics, Inc. for 610 Main Street, Cambridge, MA
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2022
Lease Amendment Agreement between 105 W. First Street Owner, L.L.C. and CRISPR Therapeutics, Inc. (January 6, 2022)
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2022
Second Amendment to Lease Agreement between 33 NYA Owner (DE) LLC and CRISPR Therapeutics, Inc.
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
DE
2021
Letter Agreement Modifying Sublease Terms Between Pfizer Inc. and CRISPR Therapeutics, Inc. Regarding Further Subleasing at 610 Main Street, Cambridge, MA
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Lease Agreement between CRP/KING 33 NY AVE. OWNER, L.L.C. and CRISPR Therapeutics, Inc. for 33 New York Avenue, Framingham, MA
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2021
First Amendment to Lease Agreement between CRP/King 33 NY Ave. Owner, L.L.C. and CRISPR Therapeutics, Inc.
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Description of CRISPR Therapeutics AG Common Shares Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Lease Agreement between 105 W First Street Owner, L.L.C. and CRISPR Therapeutics, Inc. for 105 West First Street, Boston
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2020
Underwriting Agreement between CRISPR Therapeutics AG and Underwriters for Sale of Common Shares (June 30, 2020)
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2020
Option Agreement Between Bayer Healthcare LLC and CRISPR Therapeutics AG Dated December 13, 2019
CRISPR Therapeutics AG
Biotechnology
NY
2020
Description of CRISPR Therapeutics AG Common Shares Registered under Section 12 of the Exchange Act
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2020
CRISPR Therapeutics AG Underwriting Agreement for 4,250,000 Common Shares with Goldman Sachs, Piper Jaffray, and Jefferies
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2019
Open Market Sale Agreement between CRISPR Therapeutics AG and Jefferies LLC (August 30, 2019)
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2019
Underwriting Agreement for Sale of 4,210,526 Common Shares by CRISPR Therapeutics AG to Underwriters (Goldman Sachs, Piper Jaffray, Barclays)
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2018
Open Market Sale Agreement between CRISPR Therapeutics AG and Jefferies LLC (August 31, 2018)
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2018
CRISPR Therapeutics AG Restricted Stock Award Agreement under 2018 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Restricted Stock Unit Award Agreement for Employees under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Equity Distribution Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Restricted Stock Unit Award Agreement for Non-Employee Directors under the CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2018
CRISPR Therapeutics AG Underwriting Agreement for 5,000,000 Common Shares with Goldman Sachs, Piper Jaffray, and Barclays
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2018
Non-Qualified Stock Option Agreement for Non-Employee Directors under the CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2017
CRISPR Therapeutics AG Restricted Stock Award Agreement under 2016 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Restricted Stock Unit Award Agreement for Non-Employee Directors under the CRISPR Therapeutics AG Amended and Restated 2016 Stock Option and Incentive Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Underwriting Agreement between CRISPR Therapeutics AG and Underwriters (Citigroup, Piper Jaffray, Barclays) for Common Shares Offering
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2016
Subscription Agreement between CRISPR Therapeutics AG and Bayer Global Investments B.V. (December 19, 2015)
Subscription Agreements
CRISPR Therapeutics AG
Biotechnology
2016
Registration Rights Agreement among Investors and Crispr Therapeutics AG (June 10, 2016)
Registration Rights Agreements
CRISPR Therapeutics AG
Biotechnology
2016
Crispr Therapeutics AG 2015 Stock Option and Grant Plan
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2016